Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy.
J Thorac Oncol. 2021 Jul;16(7):1200-1210. doi: 10.1016/j.jtho.2021.03.019. Epub 2021 Apr 3.
J Thorac Oncol. 2021.
PMID: 33823286
Free article.
Clinical Trial.
New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy.
Khalil AA, Hoffmann L, Moeller DS, Farr KP, Knap MM.
Khalil AA, et al. Among authors: moeller ds.
Acta Oncol. 2015;54(9):1343-9. doi: 10.3109/0284186X.2015.1061216. Epub 2015 Jul 22.
Acta Oncol. 2015.
PMID: 26198657
Item in Clipboard
Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Winther-Larsen A, Hoffmann L, Moeller DS, Khalil AA, Knap MM.
Winther-Larsen A, et al. Among authors: moeller ds.
Acta Oncol. 2015;54(9):1574-81. doi: 10.3109/0284186X.2015.1062135. Epub 2015 Jul 23.
Acta Oncol. 2015.
PMID: 26203924
Item in Clipboard
European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer.
De Ruysscher D, Faivre-Finn C, Moeller D, Nestle U, Hurkmans CW, Le Péchoux C, Belderbos J, Guckenberger M, Senan S; Lung Group and the Radiation Oncology Group of the European Organization for Research and Treatment of Cancer (EORTC).
De Ruysscher D, et al.
Radiother Oncol. 2017 Jul;124(1):1-10. doi: 10.1016/j.radonc.2017.06.003. Epub 2017 Jun 27.
Radiother Oncol. 2017.
PMID: 28666551
Item in Clipboard
Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.
Mortensen HR, Populaire P, Hoffmann L, Moeller DS, Appelt A, Nafteux P, Muijs CT, Grau C, Hawkins MA, Troost EGC, Defraene G, Canters R, Clarke CS, Weber DC, Korevaar EW, Haustermans K, Nordsmark M, Gebski V, Achiam MP, Markar SR, Radhakrishna G, Berbee M, Scartoni D, Orlandi E, Doyen J, Gregoire V, Crehange G, Langendijk J, Lorgelly P, Blommenstein HM, Byskov CS, Ehmsen ML, Jensen MF, Freixas GV, Bütof R; PROTECT consortium.
Mortensen HR, et al. Among authors: moeller ds.
Radiother Oncol. 2024 Jan;190:109980. doi: 10.1016/j.radonc.2023.109980. Epub 2023 Nov 5.
Radiother Oncol. 2024.
PMID: 37935284
No abstract available.
Item in Clipboard
Cite
Cite